- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Cancer & Blood Specialists of Louisville Adds New PET/CT Scanner to Improve Cancer Treatment
Patients to benefit from new technology that enables physicians to more accurately diagnose and locate cancers.
FORT MYERS, FLA., August 23, 2019 — Cancer & Blood Specialists of Louisville, a practice in the American Oncology Network, LLC (AON), is now offering patients a powerful new diagnostic imaging system known as positron emission tomography/computed tomography (PET/CT). This technology combines the power of hybrid imaging in one exam to enable physicians to more accurately detect and pinpoint disease—helping to improve patient outcomes.
PET/CT scans are noninvasive and painless and take about 30 minutes to perform. In addition to providing state-of-the-art imaging data, PET/CT scans offer added comfort and convenience by reducing the number of diagnostic sessions a patient must undergo.
“PET/CT scans allow for the most accurate detection of the location, size and shape of tumors and lesions," explained Jeff Esham, MBA, RT(R)(T), AON vice president of radiation oncology and radiology. "With this technology, our physicians are able to see changes within the cancer in ways that had never before been possible.”
Mental Health Awareness: Transforming Workplace Support and Engagement
May 20th 2025Explore how employers enhance workplace mental health by fostering a culture of support and engagement, focusing on holistic well-being strategies in this interview with Jim Kinville, MA, University of Pittsburgh Medical Center.
Listen
Community Oncology Reacts to Trump's Drug Pricing Executive Order
May 2nd 2025An executive order signed on Tuesday, March 15, necessitated a change in plans for this panel discussion from the 2025 Community Oncology Conference, with the assembled experts, moderated by Ted Okon, MBA, executive director of the Community Oncology Alliance, speaking to how the order would reverberate across the community oncology space.
Read More
